Trend-Following Backtester · Guide · backtest 한국어

etf · CN

Yinhua CSI Brand Name Drug Industry ETF backtest

10 trend-following strategies were compared on the full daily history of Yinhua CSI Brand Name Drug Industry ETF. 8 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 4.0%, MDD -15.4%).

Data 2020-03-20 ~ 2026-07-31daily bars 1,534 (6.4 years)Costs 0.5%Venue SZSEMonthly snapshot 2026-07-31

Results by strategy

8 of 10 beat buy and hold (CAGR -2.7%, drawdown -63.2%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 4.0%, MDD -15.4%, Sharpe 0.53, 6% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 6.7%p higher than buy and hold, while drawdown improves by 47.8%p (CAGR 4.0%, MDD -15.4%, exposure 6%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=24, threshold=28
4.0%-15.4%0.530.261.3x86%
Keltner 채널 돌파
emaPeriod=22, atrPeriod=11, mult=3.6
3.5%-17.8%0.380.201.2x67%
볼린저 밴드 돌파
n=50, k=2.6
2.5%-28.7%0.260.091.2x1015%
SMA 크로스오버
fast=47, slow=237
1.9%-23.6%0.210.081.1x631%
EMA 크로스오버
fast=57, slow=158
1.1%-31.7%0.150.041.1x832%
Supertrend
period=28, mult=3.7
-0.9%-43.3%0.05-0.020.9x3140%
MACD
fast=18, slow=34, signal=19
-1.7%-42.8%0.03-0.040.9x6747%
Parabolic SAR
step=0.005, maxStep=0.34
-3.4%-61.1%-0.06-0.060.8x5746%
Donchian 채널 돌파
entryN=43, exitN=71
-3.5%-57.0%-0.07-0.060.8x1348%
ROC 모멘텀
n=57, threshold=0.14
-1.8%-35.9%-0.09-0.050.9x3613%
Buy and hold-2.7%-63.2%0.05-0.040.8x1100%
1x 2021 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -16% -32% -47% -63% 2021 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -15.4% (2020-08-05 → 2024-03-06), prior peak not yet recovered.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next